Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Methodist Debakey Cardiovasc J ; 20(3): 65-67, 2024.
Article in English | MEDLINE | ID: mdl-38765217

ABSTRACT

Anticoagulation has been the standard therapy for treating pulmonary embolism. However, newly developed pharmacological and interventional treatment options have been shown to provide benefit for certain patient populations, depending on how they present. This column highlights the use of massive pulmonary embolism risk stratification in determining the presence of cor pulmonale and offers several key points to remember when caring for patients with a pulmonary embolism.


Subject(s)
Anticoagulants , Clinical Decision-Making , Pulmonary Embolism , Triage , Humans , Anticoagulants/therapeutic use , Decision Support Techniques , Patient Selection , Predictive Value of Tests , Pulmonary Embolism/therapy , Pulmonary Embolism/diagnostic imaging , Pulmonary Embolism/diagnosis , Pulmonary Embolism/physiopathology , Risk Assessment , Risk Factors , Thrombolytic Therapy , Treatment Outcome , Male , Aged
SELECTION OF CITATIONS
SEARCH DETAIL